Trial Profile
Phase I/II clinical trial of Perispinal Etanercept in Australian patients with Chronic Stroke
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 08 Dec 2020
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Neurological disorders; Stroke
- Focus Adverse reactions
- 01 Mar 2020 Status changed from recruiting to completed according to results published in the Expert Opinion on Investigational Drugs.
- 30 Aug 2018 Status changed from not yet recruiting to recruiting.
- 01 Jul 2016 New trial record